US Stock MarketDetailed Quotes

Cullinan Therapeutics (CGEM)

Watchlist
  • 16.330
  • +0.180+1.11%
Close May 13 16:00 ET
  • 15.990
  • -0.340-2.08%
Post 20:01 ET
1.00BMarket Cap-4.85P/E (TTM)

Cullinan Therapeutics (CGEM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.70%-46.05M
-20.95%-175.75M
-4.05%-38.11M
-8.02%-36.88M
-58.74%-57.61M
-12.83%-43.16M
-8.21%-145.3M
-102.01%-36.63M
0.01%-34.14M
-17.05%-36.29M
Net income from continuing operations
-2.39%-49.66M
-31.21%-219.88M
-6.43%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-29.89%-48.5M
-8.04%-167.58M
-86.39%-47.65M
-3.51%-40.56M
-30.47%-42.03M
Depreciation and amortization
3.95%79K
1.63%311K
2.60%79K
3.95%79K
0.00%77K
0.00%76K
-1.29%306K
0.00%77K
-5.00%76K
-4.94%77K
Change In working capital
-84.16%-3.3M
3,720.57%14.08M
27.44%6.14M
201.03%5.55M
464.81%4.19M
69.63%-1.79M
-14.75%-389K
45.65%4.82M
1,117.68%1.84M
75.30%-1.15M
-Change in prepaid assets
-138.00%-662K
379.00%6.9M
151.38%840K
-40.63%798K
235.69%3.52M
323.84%1.74M
58.41%-2.47M
50.36%-1.64M
135.27%1.34M
-235.28%-2.59M
-Change in payables and accrued expense
25.32%-2.64M
245.03%7.19M
-17.84%5.3M
853.21%4.75M
-53.53%671K
44.02%-3.54M
-62.84%2.08M
-2.24%6.46M
-86.28%498K
122.00%1.44M
Cash from discontinued investing activities
Operating cash flow
-6.70%-46.05M
-20.95%-175.75M
-4.05%-38.11M
-8.02%-36.88M
-58.74%-57.61M
-12.83%-43.16M
-8.21%-145.3M
-102.01%-36.63M
0.01%-34.14M
-17.05%-36.29M
Investing cash flow
Cash flow from continuing investing activities
-11.93%32.41M
232.04%179.99M
40.26%22.39M
239.03%67.39M
128.85%53.4M
184.08%36.81M
-480.70%-136.31M
-68.98%15.96M
146.27%19.88M
-1,628.59%-185.11M
Net PPE purchase and sale
----
---49K
---11K
----
----
----
--0
--0
--0
--0
Net investment purchase and sale
-11.93%32.41M
232.08%180.04M
40.33%22.4M
239.22%67.43M
128.85%53.4M
184.08%36.81M
-478.50%-136.31M
-68.98%15.96M
146.27%19.88M
-1,622.43%-185.11M
Cash from discontinued investing activities
Investing cash flow
-11.93%32.41M
232.04%179.99M
40.26%22.39M
239.03%67.39M
128.85%53.4M
184.08%36.81M
-480.70%-136.31M
-68.98%15.96M
146.27%19.88M
-1,628.59%-185.11M
Financing cash flow
Cash flow from continuing financing activities
380K
-99.59%1.09M
-54.80%715K
0
-99.86%373K
0
553.21%266.19M
537.90%1.58M
1,083.04%1.33M
579.23%262.2M
Net issuance payments of debt
----
----
----
----
----
----
--0
--0
--0
--0
Net common stock issuance
----
--0
--0
--0
----
----
584.20%262.65M
--0
--0
----
Proceeds from stock option exercised by employees
--380K
-86.37%1.09M
-54.80%715K
--0
-88.82%373K
--0
1,384.01%7.98M
537.90%1.58M
1,668.75%1.98M
1,458.88%3.34M
Net other financing activities
----
----
----
----
----
----
---4.45M
--0
---656K
----
Cash from discontinued financing activities
Financing cash flow
--380K
-99.59%1.09M
-54.80%715K
--0
-99.86%373K
--0
553.21%266.19M
537.90%1.58M
1,083.04%1.33M
579.23%262.2M
Net cash flow
Beginning cash position
6.42%88.33M
-15.67%83.01M
1.22%103.34M
-36.69%72.82M
3.27%76.66M
-15.67%83.01M
-36.96%98.43M
57.42%102.09M
-18.90%115.02M
-39.22%74.23M
Current changes in cash
-108.68%-13.25M
134.53%5.33M
21.37%-15M
335.89%30.52M
-109.40%-3.84M
73.77%-6.35M
73.27%-15.43M
-156.81%-19.08M
83.20%-12.94M
107.01%40.79M
End cash Position
-2.05%75.08M
6.42%88.33M
6.42%88.33M
1.22%103.34M
-36.69%72.82M
3.27%76.66M
-15.67%83.01M
-15.67%83.01M
57.42%102.09M
-18.90%115.02M
Free cash flow
-6.70%-46.05M
-20.99%-175.8M
-4.08%-38.12M
-8.13%-36.92M
-58.74%-57.61M
-12.83%-43.16M
-8.05%-145.3M
-102.01%-36.63M
0.01%-34.14M
-16.86%-36.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.70%-46.05M-20.95%-175.75M-4.05%-38.11M-8.02%-36.88M-58.74%-57.61M-12.83%-43.16M-8.21%-145.3M-102.01%-36.63M0.01%-34.14M-17.05%-36.29M
Net income from continuing operations -2.39%-49.66M-31.21%-219.88M-6.43%-50.71M-24.78%-50.61M-66.69%-70.06M-29.89%-48.5M-8.04%-167.58M-86.39%-47.65M-3.51%-40.56M-30.47%-42.03M
Depreciation and amortization 3.95%79K1.63%311K2.60%79K3.95%79K0.00%77K0.00%76K-1.29%306K0.00%77K-5.00%76K-4.94%77K
Change In working capital -84.16%-3.3M3,720.57%14.08M27.44%6.14M201.03%5.55M464.81%4.19M69.63%-1.79M-14.75%-389K45.65%4.82M1,117.68%1.84M75.30%-1.15M
-Change in prepaid assets -138.00%-662K379.00%6.9M151.38%840K-40.63%798K235.69%3.52M323.84%1.74M58.41%-2.47M50.36%-1.64M135.27%1.34M-235.28%-2.59M
-Change in payables and accrued expense 25.32%-2.64M245.03%7.19M-17.84%5.3M853.21%4.75M-53.53%671K44.02%-3.54M-62.84%2.08M-2.24%6.46M-86.28%498K122.00%1.44M
Cash from discontinued investing activities
Operating cash flow -6.70%-46.05M-20.95%-175.75M-4.05%-38.11M-8.02%-36.88M-58.74%-57.61M-12.83%-43.16M-8.21%-145.3M-102.01%-36.63M0.01%-34.14M-17.05%-36.29M
Investing cash flow
Cash flow from continuing investing activities -11.93%32.41M232.04%179.99M40.26%22.39M239.03%67.39M128.85%53.4M184.08%36.81M-480.70%-136.31M-68.98%15.96M146.27%19.88M-1,628.59%-185.11M
Net PPE purchase and sale -------49K---11K--------------0--0--0--0
Net investment purchase and sale -11.93%32.41M232.08%180.04M40.33%22.4M239.22%67.43M128.85%53.4M184.08%36.81M-478.50%-136.31M-68.98%15.96M146.27%19.88M-1,622.43%-185.11M
Cash from discontinued investing activities
Investing cash flow -11.93%32.41M232.04%179.99M40.26%22.39M239.03%67.39M128.85%53.4M184.08%36.81M-480.70%-136.31M-68.98%15.96M146.27%19.88M-1,628.59%-185.11M
Financing cash flow
Cash flow from continuing financing activities 380K-99.59%1.09M-54.80%715K0-99.86%373K0553.21%266.19M537.90%1.58M1,083.04%1.33M579.23%262.2M
Net issuance payments of debt --------------------------0--0--0--0
Net common stock issuance ------0--0--0--------584.20%262.65M--0--0----
Proceeds from stock option exercised by employees --380K-86.37%1.09M-54.80%715K--0-88.82%373K--01,384.01%7.98M537.90%1.58M1,668.75%1.98M1,458.88%3.34M
Net other financing activities ---------------------------4.45M--0---656K----
Cash from discontinued financing activities
Financing cash flow --380K-99.59%1.09M-54.80%715K--0-99.86%373K--0553.21%266.19M537.90%1.58M1,083.04%1.33M579.23%262.2M
Net cash flow
Beginning cash position 6.42%88.33M-15.67%83.01M1.22%103.34M-36.69%72.82M3.27%76.66M-15.67%83.01M-36.96%98.43M57.42%102.09M-18.90%115.02M-39.22%74.23M
Current changes in cash -108.68%-13.25M134.53%5.33M21.37%-15M335.89%30.52M-109.40%-3.84M73.77%-6.35M73.27%-15.43M-156.81%-19.08M83.20%-12.94M107.01%40.79M
End cash Position -2.05%75.08M6.42%88.33M6.42%88.33M1.22%103.34M-36.69%72.82M3.27%76.66M-15.67%83.01M-15.67%83.01M57.42%102.09M-18.90%115.02M
Free cash flow -6.70%-46.05M-20.99%-175.8M-4.08%-38.12M-8.13%-36.92M-58.74%-57.61M-12.83%-43.16M-8.05%-145.3M-102.01%-36.63M0.01%-34.14M-16.86%-36.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More